New report published by Global Info Research which offers insights on the global Spinal Cord Stimulation Devices market.
A Spinal Cord Stimulator (SCS) or Dorsal Column Stimulator (DCS) is a type of implantable neuromodulation device (sometimes called a “pain pacemaker”) that is used to send electrical signals to select areas of the spinal cord (dorsal columns) for the treatment of certain pain conditions. SCS is a consideration for people who have a pain condition that has not responded to more conservative therapy.
Click to view the full report TOC, figure and tables:
Global Spinal Cord Stimulation Devices Market: Forecast by Type / Application / Region
A spinal cord stimulator (SCS) device is surgically placed under your skin and sends a mild electric current to your spinal cord. A small wire carries the current from a pulse generator to the nerve fibers of the spinal cord. When turned on, the SCS stimulates the nerves in the area where your pain is felt. Pain is reduced because the electrical pulses modify and mask the pain signal from reaching your brain.
Market Segment by Manufacturers covers: Medtronic, Boston Scientific, Abbott (St. Jude Medical), Nevro and Nuvectra.
Market Segment by Types covers: Rechargeable and Non-Rechargeable.
Market Segment by Applications be divided into: Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, Chronic Pain and Other.
In the last several years, global market of spinal cord stimulation devices was experienced an upward trend rapidly, with an average growth rate of 5.72%. In 2017, global revenue of spinal cord stimulation devices is nearly 2.15 billion USD; the actual Sales are about 116 K Unit.
The classification of spinal cord stimulation devices includes rechargeable type and non-rechargeable type. The proportion of rechargeable type in 2017 is about 66%, and the proportion is in increasing trend from 2013 to 2017.
Spinal cord stimulation devices are widely used in failed back surgery syndrome, complex regional pain syndrome, chronic pain and other field. The most proportion of spinal cord stimulation devices is for failed back surgery syndrome, and the proportion in 2017 is 43.95%.
North America is the largest consumption place, with a consumption market share nearly 56% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 24%.
Ask for Discount on Research Report and Request Sample Copy of Report@
GlobalInfoResearch is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
United States Spinal Cord Stimulation Devices Market 2018 Forecast to 2023
Europe Spinal Cord Stimulation Devices Market 2018 Forecast to 2023
North America Spinal Cord Stimulation Devices Market 2018 Forecast to 2023
Asia-Pacific Spinal Cord Stimulation Devices Market 2018 Forecast to 2023
China Spinal Cord Stimulation Devices Market 2018 Forecast to 2023
EMEA Spinal Cord Stimulation Devices Market 2018 Forecast to 2023
Global Spinal Cord Stimulation Devices Market 2018 Forecast to 2023
Contact US :
Sales Director (Global Info Research)
Tel: +86-13660489451 00852-58197708(HK)
Add: RM 1605C HO KING COMM CTR 2-16 FA YUEN ST MONGKOK KL Hong Kong